P-033. Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey

INTRODUCTION: More than half of the intravenous drug users (IDUs) are infected with hepatitis C infection (HCV) in Turkey and there has been a trend to increase in the numbers of IDUs. Direct-acting antivirals (DAAs) have been recently reimbursed for HCV treatment. We analyzed for the efficiency and...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Turk J Gastroenterol
Main Authors: Tabak, Fehmi, Kurtaran, Behice, Zerdali, Esra, Tosun, Selma, Esen, Şaban, Öztoprak, Nefie Çuvalcı, Türker, Kamuran, Sarı, Nagehan Didem, Önlen, Yusuf, Yamazhan, Tansu, Hızel, Kenan, Group, Hepcturkey Study
פורמט: Artigo
שפה:Inglês
יצא לאור: Turkish Society of Gastroenterology 2019
נושאים:
AASLD - TASL CONNECT REGIONAL MEETING, March 15–16, 2019 - İstanbul, Turkey
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021035/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.39
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים